Alzheimer's disease, estrogens, and clinical trials: a case study in drug development for complex disorders

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Drug Development Research

• Publication date

  2005-10-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/DDR.20046
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer’s and Parkinson’s diseases

  2007cited by this paper
• Estradiol replacement enhances working memory in middle-aged rats when initiated immediately after ovariectomy but not after a long-term period of ovarian hormone deprivation.

  2006cited by this paper
• Prevention of age-related dysregulation of calcium dynamics by estrogen in neurons.

  2006cited by this paper
• News Feature: Hormone in the hot seat

  2006cited by this paper
• Integration of the extranuclear and nuclear actions of estrogen.

  2005cited by this paper
• Glycogen Synthase Kinase-3 Interacts with and Phosphorylates Estrogen Receptor α and Is Involved in the Regulation of Receptor Activity*

  2005cited by this paper
• Astrocyte-Derived Transforming Growth Factor-β Mediates the Neuroprotective Effects of 17β-Estradiol: Involvement of Nonclassical Genomic Signaling Pathways

  2005cited by this paper
• Practical guidelines for postmenopausal hormone therapy.

  2005cited by this paper
• Amyloid-β Peptide Inhibits Activation of the Nitric Oxide/cGMP/cAMP-Responsive Element-Binding Protein Pathway during Hippocampal Synaptic Plasticity

  2005cited by this paper
• Promotion of Oxidative Lipid Membrane Damage by Amyloid β Proteins

  2005cited by this paper
• Lack of oestrogen protection in amyloid-mediated endothelial damage due to protein nitrotyrosination.

  2005cited by this paper
• A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling

  2005cited by this paper
• A pilot proteomic study of amyloid precursor interactors in Alzheimer's disease

  2005cited by this paper
• Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease

  2005cited by this paper
• Ultrastructural localization of estrogen receptor β immunoreactivity in the rat hippocampal formation

  2005cited by this paper
• Expression of estrogen receptor alpha exon-deleted mRNA variants in the human and non-human primate frontal cortex.

  2005cited by this paper
• Mitochondria play a central role in estrogen-induced neuroprotection.

  2005cited by this paper
• Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo

  2005cited by this paper
• Neurovascular mechanisms of Alzheimer's neurodegeneration.

  2005cited by this paper
• Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial.

  2005cited by this paper
• Neuroprotective properties of selective estrogen receptor agonists in cultured neurons.

  2005cited by this paper
• 17β‐oestradiol up‐regulates longevity‐related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFκB cascade

  2005cited by this paper
• β-Amyloid Is Different in Normal Aging and in Alzheimer Disease*

  2005cited by this paper
• Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function

  2005cited by this paper
• Estrogen therapy fails to alter amyloid deposition in the PDAPP model of Alzheimer's disease.

  2005cited by this paper
• Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo.

  2005cited by this paper
• Estrogen-Induced Increase in the Magnitude of Long-Term Potentiation Occurs Only When the Ratio of NMDA Transmission to AMPA Transmission Is Increased

  2005cited by this paper
• Sex, Apolipoprotein E ε4 Status, and Hippocampal Volume in Mild Cognitive Impairment

  2005cited by this paper
• Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.

  2005cited by this paper
• Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease

  2005cited by this paper
• Regulation of NMDA receptor trafficking by amyloid-β

  2005cited by this paper
• Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain.

  2005cited by this paper
• Differential effects of estrogen on hippocampal- and striatal-dependent learning.

  2005cited by this paper
• Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions

  2005cited by this paper
• The Women's Health Initiative Memory Study: findings and implications for treatment.

  2005cited by this paper
• Similarities between actions of estrogen and BDNF in the hippocampus: coincidence or clue?

  2005cited by this paper
• Lessons to be learned from the Vioxx debacle

  2005cited by this paper
• Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations.

  2005cited by this paper
• Neuronal microtubules: when the MAP is the roadblock.

  2005cited by this paper
• Alteration of a Clinically Meaningful Outcome in the Natural History of Alzheimer's Disease by Cholinesterase Inhibition

  2005cited by this paper
• Estrogen and memory in women: how can we reconcile the findings?

  2005cited by this paper
• Early changes in Aβ levels in the brain of APPswe transgenic mice—Implication on synaptic density, α7 neuronal nicotinic acetylcholine- and N-methyl-d-aspartate receptor levels

  2005cited by this paper
• Estrogen receptor ligands: design and synthesis of new 2-arylindene-1-ones.

  2005cited by this paper
• Development of 17α‐Estradiol as a Neuroprotective Therapeutic Agent: Rationale and Results from a Phase I Clinical Study

  2005cited by this paper
• Glycogen synthase kinase 3β links neuroprotection by 17β-estradiol to key Alzheimer processes

  2005cited by this paper
• Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal Women: Recommendations from the U.S. Preventive Services Task Force

  2005cited by this paper
• 17β-estradiol induced Ca2+ influx via L-type calcium channels activates the Src/ERK/cyclic-AMP response element binding protein signal pathway and BCL-2 expression in rat hippocampal neurons: A potential initiation mechanism for estrogen-induced neuroprotection

  2005cited by this paper
• High β-Secretase Activity Elicits Neurodegeneration in Transgenic Mice Despite Reductions in Amyloid-β Levels

  2005cited by this paper
• 17β-Estradiol Inhibits Inflammatory Gene Expression by Controlling NF-κB Intracellular Localization

  2005cited by this paper
• Estradiol and raloxifene protect cultured SN4741 neurons against oxidative stress.

  2005cited by this paper
• Evidence of increased oxidative damage in subjects with mild cognitive impairment

  2005cited by this paper
• The 17α and 17β Isomers of Estradiol Both Induce Rapid Spine Synapse Formation in the CA1 Hippocampal Subfield of Ovariectomized Female Rats

  2005cited by this paper
• ROTEOMIC IDENTIFICATION OF PROTEINS SPECIFICALLY OXIDIZED Y INTRACEREBRAL INJECTION OF AMYLOID-PEPTIDE ( 1 – 42 ) NTO RAT BRAIN : IMPLICATIONS FOR ALZHEIMER ’ S DISEASE

  2005cited by this paper
• Conditional Inactivation of Presenilin 1 Prevents Amyloid Accumulation and Temporarily Rescues Contextual and Spatial Working Memory Impairments in Amyloid Precursor Protein Transgenic Mice

  2005cited by this paper
• Estrogen receptor ligands. Part 13: Dihydrobenzoxathiin SERAMs with an optimized antagonist side chain.

  2005cited by this paper
• The synthetic estrogen 4-estren-3α, 17β-diol (estren) induces estrogen-like neuroprotection

  2005cited by this paper
• Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦

  2005cited by this paper
• Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients.

  2005cited by this paper
• Microtubule Regulation of N-Methyl-D-aspartate Receptor Channels in Neurons*

  2005cited by this paper
• Abeta42 is essential for parenchymal and vascular amyloid deposition in mice.

  2005cited by this paper
• Proteomic identification of proteins oxidized by Abeta(1-42) in synaptosomes: implications for Alzheimer's disease.

  2005cited by this paper
• Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross-over study.

  2005cited by this paper
• Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.

  2005cited by this paper
• 17β-estradiol induces Ca2+ influx, dendritic and nuclear Ca2+ rise and subsequent cyclic AMP response element-binding protein activation in hippocampal neurons: A potential initiation mechanism for estrogen neurotrophism

  2005cited by this paper
• 17α-Estradiol: A Brain-Active Estrogen?

  2005cited by this paper
• Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model.

  2005cited by this paper
• Selective sparing of brain tissue in postmenopausal women receiving hormone replacement therapy.

  2005cited by this paper
• Estradiol Activates Group I and II Metabotropic Glutamate Receptor Signaling, Leading to Opposing Influences on cAMP Response Element-Binding Protein

  2005cited by this paper
• Role of Protein Phosphatases in Estrogen-Mediated Neuroprotection

  2005cited by this paper
• New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.

  2005cited by this paper
• The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study.

  2005cited by this paper
• Dendritic Spine Abnormalities in Amyloid Precursor Protein Transgenic Mice Demonstrated by Gene Transfer and Intravital Multiphoton Microscopy

  2005cited by this paper
• A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

  2005cited by this paper
• Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory

  2005cited by this paper
• Direct, complex effects of estrogens on basal forebrain cholinergic neurons.

  2005cited by this paper
• Color-coded diffusion-tensor-imaging of posterior cingulate fiber tracts in mild cognitive impairment.

  2005cited by this paper
• Axonal Transport, Amyloid Precursor Protein, Kinesin-1, and the Processing Apparatus: Revisited

  2005cited by this paper
• Mitochondrial abnormalities in Alzheimer brain: Mechanistic implications

  2005cited by this paper
• Gonadal hormone modulation of dendrites in the mammalian CNS.

  2005cited by this paper
• Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease

  2005cited by this paper
• Age-related cognitive decline in the menopause: effects of hormone replacement therapy on cognitive event-related potentials.

  2005cited by this paper
• Controversies about HRT--lessons from monkey models.

  2005cited by this paper
• Current opinions and understandings of menopausal women about hormone replacement therapy (HRT)-the University of Florida experience.

  2004cited by this paper
• Expanded coverage of the human heart mitochondrial proteome using multidimensional liquid chromatography coupled with tandem mass spectrometry.

  2004cited by this paper
• Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study

  2004cited by this paper
• Differential Roles of NR2A and NR2B-Containing NMDA Receptors in Cortical Long-Term Potentiation and Long-Term Depression

  2004cited by this paper
• Estradiol inhibits GSK3 and regulates interaction of estrogen receptors, GSK3, and beta-catenin in the hippocampus.

  2004cited by this paper
• Structural plasticity and memory

  2004cited by this paper
• Estrogen use and brain metabolic change in postmenopausal women.

  2004cited by this paper
• Presynaptic N‐methyl‐D‐aspartate receptor expression is increased by estrogen in an aromatase‐rich area of the songbird hippocampus

  2004cited by this paper
• Quantitative Proteomic Analysis of Mitochondria from Primary Neuron Cultures Treated with Amyloid Beta Peptide

  2004cited by this paper
• Role of Hydrogen Peroxide in the Aetiology of Alzheimer’s Disease

  2004cited by this paper
• A novel CDK5‐dependent pathway for regulating GSK3 activity and kinesin‐driven motility in neurons

  2004cited by this paper
• Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer’s disease

  2004cited by this paper
• Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease.

  2004cited by this paper
• Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses

  2004cited by this paper
• β-Amyloid-Mediated Inhibition of NMDA Receptor-Dependent Long-Term Potentiation Induction Involves Activation of Microglia and Stimulation of Inducible Nitric Oxide Synthase and Superoxide

  2004cited by this paper
• Estrogen- and tamoxifen-associated effects on brain structure and function

  2004cited by this paper
• Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication.

  2004cited by this paper
• Mitochondrial localization of estrogen receptor β

  2004cited by this paper

• Effects of Tibolone on the Central Nervous System: Clinical and Experimental Approaches

  2017cites this paper
• A comparative evaluation of treatments with 17β-estradiol and its brain-selective prodrug in a double-transgenic mouse model of Alzheimer's disease.

  2016cites this paper
• Mitochondrial Drugs Come of Age

  2015cites this paper
• Review of the effects of 17α‐estradiol in humans: a less feminizing estrogen with neuroprotective potential

  2009influential citation
• 17α‐estradiol: a less‐feminizing estrogen

  2008cites this paper
• Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system.

  2007influential citation
• Title : Novel perspectives for progesterone in HRT, with special reference to the nervous system

  2007cites this paper